Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
about
Risk of cancer in diabetes: the effect of metforminThe Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyInsidious changes in stromal matrix fuel cancer progressionObesity and cancer: at the crossroads of cellular metabolism and proliferationIs there a role for IGF-1 in the development of second primary cancers?The interplay between obesity and cancer: a fly viewA prospective study of plasma C-peptide and colorectal cancer risk in menA pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammationCirculating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohortsMetabolic abnormalities and risk for colorectal cancer in the physicians' health studyPlasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern SwedenIGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in ShanghaiA Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancerIGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?Obesity and cancer pathogenesis.The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesAdiponectin supports cell survival in glucose deprivation through enhancement of autophagic response in colorectal cancer cells.A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease riskA Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskLocal IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas.Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia.Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesSignificantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based studyInsulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps.Modulating human aging and age-associated diseases.Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutritionInsulin-like growth factor-I and cancer mortality in older men.Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)Physical activity and male colorectal cancer survival.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study.The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea: Relationship to Abdominal Obesity and Age.Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer.Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study.IRS-2 G1057D polymorphism in Turkish patients with colorectal cancerGlucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells.
P2860
Q21284807-9A0E7032-FBE5-46B0-A7D9-DE99261750C4Q26777125-1D2A940F-86B4-48F7-81CF-7D33D50AA13EQ26851261-84967449-742F-4454-B07C-F9D1F90EBDFAQ27003989-A58F5F29-6EEF-4D3C-B4C5-84F79338E0BEQ28069262-5AF04981-78F2-43A9-BEC2-5893E742FAEAQ28079088-D4793414-1AE7-45BD-AFAC-26FFA42294DEQ28168133-5E3F6B77-CD06-4746-8C11-71F120B8FFA1Q28190164-1ECAD3C6-809E-4ED8-9598-51AF309BE68DQ28211600-31D15B8C-751A-44B8-9F97-485924B18EF5Q28212410-4B9D8F73-C11A-4EDC-A8FA-527B2D66E592Q28214565-E1841884-106D-4DBD-A6D5-95B863F18476Q28366237-7DA3D180-795D-4005-9330-581122309ECBQ28601163-E59EB0B7-8F06-4E8C-BC55-699E7C4AB7B8Q28740805-925B7AA5-3AF0-4832-9F7C-88BBF6F54FC0Q30320919-C5A893BE-78DE-490C-B4E4-472D8A0AEC02Q30361298-2F625068-BB7E-4BBB-9923-6A6CA0DB7975Q30404178-9F25965C-FE82-4C48-B977-333968944E09Q30502502-B3811905-BE70-4849-80E5-861C6AF466A5Q30998452-6011A4C6-461A-42B0-A4D7-FEA74DCED6C0Q31013593-E496C2CE-F418-4347-8A38-CEBE61F1BE66Q31049602-A064BDC4-6AC1-4617-8E88-4677A4854B8DQ33337232-234D9B7A-3038-4BAD-A66A-7DFC1A581ABDQ33424008-9F5C487B-C4C2-4EF7-8DE0-79FAD6A31C6BQ33556805-F1DA3A64-CE9C-4971-A265-6B5EB9B66914Q33578887-7CB4180B-F12E-4C35-883F-5EEBFFDE6564Q33632980-63C73002-E808-4417-9814-4977CFB21AE3Q33636626-7E997213-9D90-48E1-94E7-D8815FB38D17Q33693445-E40FB5F4-A7F7-43B4-BCFF-061965CA7FC5Q33716534-2B00BF8D-49FF-4B97-84D8-8A3F7C096849Q33738660-31A716B1-220D-457C-80D4-78C142FDDA0EQ33768908-BA02FB56-8054-4A78-ADC3-094CD39BCD2AQ33779574-A4110289-8C44-4DCA-9C61-F1992BD8591FQ33791812-656D8EF9-0F00-4A5C-BE58-E65F8DC6E6F8Q33852892-E8CE77F3-7AC2-4CCB-9DF3-1D182CD9EAEAQ33855690-5B699FCC-64F1-4023-B38F-EC260EAE0299Q33866187-E1876134-A6C1-4A3A-887F-C378C34B09BAQ33903099-97F5E4A7-EED4-410A-8D88-F40F0AAFB682Q33924554-52996E46-BE4E-4D89-81A1-89A0845709E2Q33941364-88633EB9-217D-4A7F-9E40-A65BED1962CEQ33987816-564ABF7F-08B5-4B7D-BB4D-DF80A5C080C8
P2860
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@en
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@nl
type
label
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@en
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@nl
prefLabel
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@en
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@nl
P2093
P50
P356
P1476
Serum C-peptide, insulin-like ...... lorectal cancer risk in women.
@en
P2093
Akhmedkhanov A
Lukanova A
P304
P356
10.1093/JNCI/92.19.1592
P407
P577
2000-10-01T00:00:00Z